Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Liposomal Bupivacaine Using Periarticular Injection for in Total Knee Arthroplasty: a Prospective, Randomized, Controlled Study

NCT06557018 is registered in ClinicalTrials.gov with Dezhou Hospital Qilu Hospital of Shandong University as lead sponsor.

NCT NCT06557018
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06557018 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Liposomal Bupivacaine Using Periarticular Injection for in Total Knee Arthroplasty: a Prospective, Randomized, Controlled Study
Lead sponsor
Dezhou Hospital Qilu Hospital of Shandong University
Phase
Phase 4
Overall status
Recruiting
Start date
June 25, 2024
Completion date
September 15, 2024
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

osteoarthritis, knee